Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion type Assertion NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_head.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion description "[Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion evidence source_evidence_literature NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion SIO_000772 14605330 NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion wasDerivedFrom gad-20150221 NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.
- NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_assertion wasGeneratedBy ECO_0000203 NP64633.RA6F-OQ0ydjdshE2bOjrS0qXy3PjP3G_RFFG2vc2-CMLc130_provenance.